Shionogi-Backed Biotech Apnimed Raises $192 Million in US IPO
Original Report
Apnimed Inc., a late-stage drug developer focused on sleep apnea, raised $192 million in an upsized US initial public offering, priced at the top of a marketed range.
Glass House Analysis
Inflation is the silent tax that erodes purchasing power, hitting hardest those who can least afford it. When grocery bills rise faster than wages, families face impossible choices between food, medicine, and rent. Unlike market volatility that mainly affects investors, inflation touches everyone who buys groceries, fills a gas tank, or pays rent.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
BOJ holds rates at 1%, warns of core inflation exceeding 2% target
The decision comes as speculation continues to swirl around whether the Bank of Japan will hike rates at a faster pace.
Swiggy, Eternal Stocks Surge as Zepto’s India IPO Hits Roadblock
Shares of the main competitors to Indian rapid-commerce firm Zepto Ltd. are set for their best month in years after the loss-making company’s planned initial public offering hit a roadblock.
China's factory activity unexpectedly contracts in July on demand slump, typhoons
China's factory activity unexpectedly contracted in July, as the export rush that powered a second-quarter rebound began to unwind.
BOJ Holds Rate Steady And Upgrades View on Economy
The Bank of Japan kept its policy settings unchanged and nudged its economic growth forecast higher, signaling confidence that the economy remains on track for further policy normalization....